A

ATHOS

Description

ATHOS is a well-known single-family office dedicated to advancing cutting-edge technologies and creating revolutionary businesses

Investor Profile

ATHOS has made 4 investments, with 2 in the past 12 months and 50% as lead.

Stage Focus

  • Private Equity (50%)
  • Series A (25%)
  • Series B (25%)

Country Focus

  • Germany (75%)
  • Denmark (25%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Medical Device
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Health Diagnostics
  • Machine Learning
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ATHOS frequently co-invest with?

Bill & Melinda Gates Foundation
North America, New York, United States, New York
Co-Investments: 1
European Equity Partners
Europe, England, United Kingdom, London
Co-Investments: 1
Nextech Invest
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 1
Qatar Investment Authority
Asia, Ad Dawhah, Qatar, Doha
Co-Investments: 2
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 1
BlackRock
North America, New York, United States, New York
Co-Investments: 2
CF
Europe, Bayern, Germany, Munich
Co-Investments: 1
C
Europe, Hamburg, Germany, Hamburg
Co-Investments: 2

What are some of recent deals done by ATHOS?

Aignostics

Berlin, Berlin, Germany

Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research.

Artificial Intelligence (AI)Health CareHealth DiagnosticsMachine LearningSoftware
Series BOct 29, 2024
Amount Raised: $34,000,000
Isotopen Technologien München

Garching, Bayern, Germany

Isotopen Technologien München is a holding company that owns biotechnology and radiopharmaceutical companies.

BiopharmaBiotechnologyMedical DevicePharmaceutical
Private EquityJun 6, 2024
Amount Raised: $204,565,065
Bactolife

Lyngby, Hovedstaden, Denmark

Bactolife helps in developing innovative solutions meeting the global need for reducing antimicrobial resistance.

BiotechnologyHealth Care
Series AAug 8, 2023
Amount Raised: $32,878,081
Isotopen Technologien München

Garching, Bayern, Germany

Isotopen Technologien München is a holding company that owns biotechnology and radiopharmaceutical companies.

BiopharmaBiotechnologyMedical DevicePharmaceutical
Private EquityJun 5, 2023
Amount Raised: $273,139,465